Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2010

01-05-2010 | Educational Series

Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment

Authors: Francesc Casas, Josep María Borràs, Ferran Ferrer, Núria Guanyabens, Rafael Gutiérrez del Pozo, Concha León, José López Torrecilla, Begoña Mellado, Joan Morote, Manel Puig, María José Ribal, Carme Ruscalleda, Agustí Serra, Valentí Valls, Almudena Zapatero

Published in: Clinical and Translational Oncology | Issue 5/2010

Login to get access
Metadata
Title
Evidence-based consensus recommendations to improve the quality of life in prostate cancer treatment
Authors
Francesc Casas
Josep María Borràs
Ferran Ferrer
Núria Guanyabens
Rafael Gutiérrez del Pozo
Concha León
José López Torrecilla
Begoña Mellado
Joan Morote
Manel Puig
María José Ribal
Carme Ruscalleda
Agustí Serra
Valentí Valls
Almudena Zapatero
Publication date
01-05-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 5/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0516-6

Other articles of this Issue 5/2010

Clinical and Translational Oncology 5/2010 Go to the issue

Educational Series

Lymphoma of the testis as primary location: tumour review

Research Articles

Use of an electron spoiler for radiation treatment of surface skin diseases

Case Reports

Haemolytic uraemic syndrome associated with gemcitabine

Editorial

Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

Special Article

TTD consensus document on the diagnosis and management of hereditary colorectal cancer

Correspondence

Is it the right time for multidisciplinarity in Spanish clinical oncology? I think so
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits